Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	3.71e-10	18	210	7	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.26e-08	28	210	7	GO:0051959
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO6 DNAH8 DNAH3 DNAH10 DNAH2 MYO1B DNAH7 DNAH1 DNAL4 DNAH12 MYO15A	4.80e-08	118	210	11	GO:0003774
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.01e-07	37	210	7	GO:0045505
GeneOntologyMolecularFunction	microtubule motor activity	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	7.07e-07	70	210	8	GO:0003777
GeneOntologyMolecularFunction	ATP-dependent activity	ABCF3 ATRX MYO6 ABCA13 NAIP ABCB1 ABCG2 DNAH8 RAD51C ABCC1 DNAH3 DNAH10 DNAH2 RNF213 MYO1B DNAH7 DNAH1 DNAL4 DNAH12 CHD5 MYO15A	2.24e-06	614	210	21	GO:0140657
GeneOntologyMolecularFunction	voltage-gated monoatomic anion channel activity	CLCN4 GPR89A GPR89B ANO1	2.54e-05	17	210	4	GO:0008308
GeneOntologyMolecularFunction	monoatomic ion channel activity	GABRR2 PKD1L2 RYR3 CLCN4 TRPM3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 LRRC8A	3.02e-05	459	210	16	GO:0005216
GeneOntologyMolecularFunction	D2 dopamine receptor binding	DNM1 DNM2 GRIN2B	3.89e-05	7	210	3	GO:0031749
GeneOntologyMolecularFunction	sphingolipid transporter activity	ABCB1 ABCG2 ABCC1 MTTP	5.05e-05	20	210	4	GO:0046624
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCF3 ATRX ABCA13 NAIP ABCB1 ABCG2 DNAH8 ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12 CHD5	7.07e-05	441	210	15	GO:0016887
GeneOntologyMolecularFunction	protein serine/threonine kinase binding	NAIP AKT1 DNM1 DNM2	1.07e-04	24	210	4	GO:0120283
GeneOntologyMolecularFunction	sweet taste receptor activity	TAS1R3 TAS1R2	1.10e-04	2	210	2	GO:0033041
GeneOntologyMolecularFunction	voltage-gated monoatomic ion channel activity	CLCN4 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIN2B	1.36e-04	182	210	9	GO:0005244
GeneOntologyMolecularFunction	channel activity	GABRR2 PKD1L2 RYR3 CLCN4 TRPM3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 LRRC8A	1.46e-04	525	210	16	GO:0015267
GeneOntologyMolecularFunction	voltage-gated channel activity	CLCN4 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIN2B	1.48e-04	184	210	9	GO:0022832
GeneOntologyMolecularFunction	passive transmembrane transporter activity	GABRR2 PKD1L2 RYR3 CLCN4 TRPM3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 LRRC8A	1.49e-04	526	210	16	GO:0022803
GeneOntologyMolecularFunction	gated channel activity	GABRR2 RYR3 CLCN4 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B	2.29e-04	334	210	12	GO:0022836
GeneOntologyMolecularFunction	hedgehog receptor activity	PTCH1 PTCH2	3.28e-04	3	210	2	GO:0008158
GeneOntologyMolecularFunction	taste receptor activity	TAS2R8 TAS1R3 PKD1L3 TAS1R2	3.83e-04	33	210	4	GO:0008527
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCB1 ABCG2 ABCC1	4.75e-04	15	210	3	GO:0008559
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCF3 ATRX ABCA13 LRRK2 NAIP ABCB1 ABCG2 DNM1 DNAH8 DNM2 ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12 GPN2 CHD5	5.62e-04	775	210	19	GO:0017111
GeneOntologyMolecularFunction	efflux transmembrane transporter activity	ABCB1 ABCG2 ABCC1	5.80e-04	16	210	3	GO:0015562
GeneOntologyMolecularFunction	smoothened binding	PTCH1 PTCH2	6.51e-04	4	210	2	GO:0005119
GeneOntologyMolecularFunction	hedgehog family protein binding	PTCH1 PTCH2	6.51e-04	4	210	2	GO:0097108
GeneOntologyMolecularFunction	monoatomic anion channel activity	GABRR2 CLCN4 GPR89A GPR89B ANO1 LRRC8A	7.72e-04	103	210	6	GO:0005253
GeneOntologyMolecularFunction	transporter activity	GABRR2 ABCA13 PKD1L2 RYR3 ABCB1 CLCN4 SLC41A3 TRPM3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 ABCG2 GPR89B ABCC1 SLC9A8 APOA5 ANO1 GRIA4 APOB GRIN2B PKD1L3 MTTP LRRC8A SLC38A6	1.08e-03	1289	210	26	GO:0005215
GeneOntologyMolecularFunction	lipid transporter activity	ABCA13 ABCB1 ABCG2 ABCC1 APOA5 ANO1 APOB MTTP	1.13e-03	196	210	8	GO:0005319
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCF3 ATRX ABCA13 LRRK2 NAIP ABCB1 ABCG2 DNM1 DNAH8 DNM2 ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12 GPN2 CHD5	1.43e-03	839	210	19	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCF3 ATRX ABCA13 LRRK2 NAIP ABCB1 ABCG2 DNM1 DNAH8 DNM2 ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12 GPN2 CHD5	1.45e-03	840	210	19	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCF3 ATRX ABCA13 LRRK2 NAIP ABCB1 ABCG2 DNM1 DNAH8 DNM2 ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12 GPN2 CHD5	1.45e-03	840	210	19	GO:0016818
GeneOntologyMolecularFunction	nitric-oxide synthase binding	DNM1 DNM2 CDH2	1.52e-03	22	210	3	GO:0050998
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA13 ABCB1 ABCG2 ABCC1	1.74e-03	49	210	4	GO:0140359
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	GABRR2 PKD1L2 RYR3 CLCN4 SLC41A3 TRPM3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B SLC9A8 ANO1 GRIA4 GRIN2B PKD1L3 LRRC8A	1.86e-03	793	210	18	GO:0015075
GeneOntologyMolecularFunction	cholesterol transfer activity	APOA5 APOB MTTP	1.97e-03	24	210	3	GO:0120020
GeneOntologyMolecularFunction	sterol transfer activity	APOA5 APOB MTTP	2.22e-03	25	210	3	GO:0120015
GeneOntologyMolecularFunction	lipase binding	APOA5 APOB	2.23e-03	7	210	2	GO:0035473
GeneOntologyMolecularFunction	dopamine receptor binding	DNM1 DNM2 GRIN2B	2.49e-03	26	210	3	GO:0050780
GeneOntologyBiologicalProcess	cilium movement involved in cell motility	NPHP4 CCNYL1 TACR3 DNAH8 DNAH3 DNAH10 DNAH2 APOB DNAH7 DNAH1 DNAH12	1.13e-05	210	211	11	GO:0060294
GeneOntologyBiologicalProcess	cilium-dependent cell motility	NPHP4 CCNYL1 TACR3 DNAH8 DNAH3 DNAH10 DNAH2 APOB DNAH7 DNAH1 DNAH12	1.41e-05	215	211	11	GO:0060285
GeneOntologyBiologicalProcess	cilium or flagellum-dependent cell motility	NPHP4 CCNYL1 TACR3 DNAH8 DNAH3 DNAH10 DNAH2 APOB DNAH7 DNAH1 DNAH12	1.41e-05	215	211	11	GO:0001539
GeneOntologyBiologicalProcess	cilium movement	ADCY10 NPHP4 CCNYL1 TACR3 DNAH8 DNAH3 DNAH10 DNAH2 APOB DNAH7 DNAH1 DNAH12	1.67e-05	261	211	12	GO:0003341
GeneOntologyBiologicalProcess	xenobiotic transport across blood-brain barrier	ABCB1 ABCG2 ABCC1	2.06e-05	6	211	3	GO:1990962
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	2.06e-10	10	212	6	GO:0036156
GeneOntologyCellularComponent	axonemal dynein complex	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	4.11e-09	25	212	7	GO:0005858
GeneOntologyCellularComponent	dynein complex	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	6.84e-08	54	212	8	GO:0030286
GeneOntologyCellularComponent	microtubule associated complex	MAP1B DNAH8 DNAH3 DNAH10 FNTB DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	5.97e-06	161	212	10	GO:0005875
GeneOntologyCellularComponent	9+2 motile cilium	TACR3 IL4I1 DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12 TMEM249 RNF38 CFAP74	6.07e-06	238	212	12	GO:0097729
GeneOntologyCellularComponent	cilium	ADCY10 MAP1B PTCH1 NPHP4 CLCN4 ALMS1 KCNF1 AKT1 TACR3 IL4I1 DNAH8 DNAH3 DNAH10 DNAH2 TSPEAR DNAH7 DNAH1 DNAL4 DNAH12 TBC1D31 TMEM249 TTLL4 RNF38 CFAP74	1.51e-05	898	212	24	GO:0005929
GeneOntologyCellularComponent	monoatomic ion channel complex	GABRR2 RYR3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 TMEM249 LRRC8A	3.40e-05	378	212	14	GO:0034702
GeneOntologyCellularComponent	leading edge membrane	MYO6 PLXND1 KCNH1 AKT2 TACR3 DNM2 CIB1 ITGA8 EPB41L5 MTMR6	5.92e-05	210	212	10	GO:0031256
GeneOntologyCellularComponent	motile cilium	ADCY10 TACR3 IL4I1 DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12 TMEM249 RNF38 CFAP74	7.28e-05	355	212	13	GO:0031514
GeneOntologyCellularComponent	sweet taste receptor complex	TAS1R3 TAS1R2	1.02e-04	2	212	2	GO:1903767
GeneOntologyCellularComponent	taste receptor complex	TAS1R3 TAS1R2	1.02e-04	2	212	2	GO:1903768
GeneOntologyCellularComponent	laminin complex	LAMA3 LAMC1 LAMC2	1.17e-04	10	212	3	GO:0043256
GeneOntologyCellularComponent	cell projection membrane	MYO6 PLXND1 PTCH1 KCNH1 AKT2 ABCG2 TACR3 DNM2 CIB1 TSPEAR ITGA8 EPB41L5 MTMR6 MTTP	1.37e-04	431	212	14	GO:0031253
GeneOntologyCellularComponent	laminin-5 complex	LAMA3 LAMC2	6.06e-04	4	212	2	GO:0005610
GeneOntologyCellularComponent	IPAF inflammasome complex	NAIP NLRC4	6.06e-04	4	212	2	GO:0072557
GeneOntologyCellularComponent	canonical inflammasome complex	NAIP NLRC4 CARD8	7.50e-04	18	212	3	GO:0061702
GeneOntologyCellularComponent	ruffle membrane	MYO6 AKT2 DNM2 CIB1 EPB41L5 MTMR6	8.22e-04	108	212	6	GO:0032587
GeneOntologyCellularComponent	transmembrane transporter complex	GABRR2 RYR3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 TMEM249 LRRC8A	9.49e-04	523	212	14	GO:1902495
GeneOntologyCellularComponent	axoneme	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12 CFAP74	1.28e-03	207	212	8	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12 CFAP74	1.32e-03	208	212	8	GO:0097014
GeneOntologyCellularComponent	external side of apical plasma membrane	ABCB1 ABCG2	1.49e-03	6	212	2	GO:0098591
GeneOntologyCellularComponent	transporter complex	GABRR2 RYR3 KCNF1 KCNH1 SCN2A GPR89A KCNS1 GPR89B ANO1 GRIA4 GRIN2B PKD1L3 TMEM249 LRRC8A	1.53e-03	550	212	14	GO:1990351
GeneOntologyCellularComponent	sperm flagellum	TACR3 IL4I1 DNAH8 DNAH2 DNAH1 TMEM249 RNF38 CFAP74	1.58e-03	214	212	8	GO:0036126
GeneOntologyCellularComponent	glutamatergic synapse	SYN3 MAP1B MYO6 LRRK2 PLXND1 SCN2A AKT1 DNM1 FBXO45 DNM2 NEDD4L ANO1 ITGA8 GRIA4 GRIN2B PIAS1 PTPRT CDH2	1.74e-03	817	212	18	GO:0098978
GeneOntologyCellularComponent	postsynaptic density	SYN3 MAP1B MYO6 ADD1 KCNH1 FBXO45 DNM2 ITGA8 GRIA4 GRIN2B PTPRT CDH2	2.28e-03	451	212	12	GO:0014069
MousePheno	hydronephrosis	DIS3L2 SLC41A3 DNM2 NEDD4L LAMC1 FRYL LRRC8A MAPK7 GEN1	8.96e-06	109	175	9	MP:0000519
MousePheno	abnormal kidney pelvis morphology	DIS3L2 SLC41A3 DNM2 NEDD4L LAMC1 FRYL LRRC8A MAPK7 GEN1	2.54e-05	124	175	9	MP:0004194
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	6.38e-11	14	209	7	IPR024317
Domain	Dynein_heavy_dom-2	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	6.38e-11	14	209	7	IPR013602
Domain	DHC_N2	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	6.38e-11	14	209	7	PF08393
Domain	AAA_8	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	6.38e-11	14	209	7	PF12780
Domain	DHC_fam	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.19e-10	15	209	7	IPR026983
Domain	Dynein_heavy	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.19e-10	15	209	7	PF03028
Domain	Dynein_heavy_dom	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.19e-10	15	209	7	IPR004273
Domain	AAA	ABCF3 ABCA13 NAIP ABCB1 ABCG2 DNAH8 RAD51C ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12	8.56e-10	144	209	14	SM00382
Domain	AAA+_ATPase	ABCF3 ABCA13 NAIP ABCB1 ABCG2 DNAH8 RAD51C ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH12	8.56e-10	144	209	14	IPR003593
Domain	Dynein_HC_stalk	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1	5.09e-09	14	209	6	IPR024743
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH3 DNAH10 DNAH2 DNAH1 DNAH12	5.09e-09	14	209	6	IPR011704
Domain	MT	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1	5.09e-09	14	209	6	PF12777
Domain	AAA_5	DNAH8 DNAH3 DNAH10 DNAH2 DNAH1 DNAH12	5.09e-09	14	209	6	PF07728
Domain	P-loop_NTPase	ADCY10 ABCF3 ATRX MYO6 ABCA13 LRRK2 NAIP GAL3ST2 NLRC4 ABCB1 NWD2 ABCG2 DNM1 DNAH8 DNM2 RAD51C ABCC1 DNAH3 DNAH10 DNAH2 RNF213 MYO1B DNAH7 DNAH1 DNAH12 GPN2 CHD5 MYO15A	2.90e-07	848	209	28	IPR027417
Domain	-	ADCY10 ABCF3 ATRX ABCA13 LRRK2 NAIP NLRC4 ABCB1 NWD2 ABCG2 DNM1 DNAH8 DNM2 RAD51C ABCC1 DNAH3 DNAH10 DNAH2 RNF213 DNAH7 DNAH1 DNAH12 GPN2 CHD5 MYO15A	1.02e-06	746	209	25	3.40.50.300
Domain	LAMININ_IVA	LAMC3 LAMA3 LAMC1 LAMC2	1.03e-06	8	209	4	PS51115
Domain	Laminin_B	LAMC3 LAMA3 LAMC1 LAMC2	1.03e-06	8	209	4	PF00052
Domain	LamB	LAMC3 LAMA3 LAMC1 LAMC2	1.03e-06	8	209	4	SM00281
Domain	Laminin_IV	LAMC3 LAMA3 LAMC1 LAMC2	1.03e-06	8	209	4	IPR000034
Domain	EGF_LAM_2	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	1.90e-05	30	209	5	PS50027
Domain	EGF_LAM_1	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	1.90e-05	30	209	5	PS01248
Domain	Laminin_N	LAMC3 LAMB4 LAMA3 LAMC1	2.50e-05	16	209	4	IPR008211
Domain	LamNT	LAMC3 LAMB4 LAMA3 LAMC1	2.50e-05	16	209	4	SM00136
Domain	LAMININ_NTER	LAMC3 LAMB4 LAMA3 LAMC1	2.50e-05	16	209	4	PS51117
Domain	Laminin_N	LAMC3 LAMB4 LAMA3 LAMC1	2.50e-05	16	209	4	PF00055
Domain	EGF_Lam	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	4.13e-05	35	209	5	SM00180
Domain	Laminin_EGF	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	4.13e-05	35	209	5	PF00053
Domain	Laminin_EGF	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	6.22e-05	38	209	5	IPR002049
Domain	DHC_N1	DNAH8 DNAH10 DNAH2	7.42e-05	8	209	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH8 DNAH10 DNAH2	7.42e-05	8	209	3	IPR013594
Domain	Vitellinogen_b-sht_N	APOB MTTP	1.25e-04	2	209	2	IPR015816
Domain	Lipid_transp_b-sht_shell	APOB MTTP	1.25e-04	2	209	2	IPR015819
Domain	Factor_5/8	F5 F8	1.25e-04	2	209	2	IPR024715
Domain	-	APOB MTTP	1.25e-04	2	209	2	2.30.230.10
Domain	VITELLOGENIN	APOB MTTP	1.25e-04	2	209	2	PS51211
Domain	TM_rcpt_patched	PTCH1 PTCH2	1.25e-04	2	209	2	IPR004766
Domain	LPD_N	APOB MTTP	1.25e-04	2	209	2	SM00638
Domain	Lipid_transpt_N	APOB MTTP	1.25e-04	2	209	2	IPR001747
Domain	-	APOB MTTP	1.25e-04	2	209	2	1.25.10.20
Domain	Vitellogenin_N	APOB MTTP	1.25e-04	2	209	2	PF01347
Domain	ABC_tran	ABCF3 ABCA13 ABCB1 ABCG2 ABCC1	1.94e-04	48	209	5	PF00005
Domain	ABC_TRANSPORTER_2	ABCF3 ABCA13 ABCB1 ABCG2 ABCC1	1.94e-04	48	209	5	PS50893
Domain	ABC_TRANSPORTER_1	ABCF3 ABCA13 ABCB1 ABCG2 ABCC1	2.14e-04	49	209	5	PS00211
Domain	ABC_transporter-like	ABCF3 ABCA13 ABCB1 ABCG2 ABCC1	2.35e-04	50	209	5	IPR003439
Domain	Vitellinogen_superhlx	APOB MTTP	3.71e-04	3	209	2	IPR011030
Domain	Tensin_PTB	TNS3 TNS2	7.37e-04	4	209	2	IPR033929
Domain	ANF_lig-bd_rcpt	TAS1R3 GRIA4 GRIN2B TAS1R2	7.53e-04	37	209	4	IPR001828
Domain	ANF_receptor	TAS1R3 GRIA4 GRIN2B TAS1R2	7.53e-04	37	209	4	PF01094
Domain	Peripla_BP_I	TAS1R3 GRIA4 GRIN2B TAS1R2	9.22e-04	39	209	4	IPR028082
Domain	Cu-oxidase_3	F5 F8	1.22e-03	5	209	2	IPR011707
Domain	MULTICOPPER_OXIDASE1	F5 F8	1.22e-03	5	209	2	PS00079
Domain	Cu_oxidase_CS	F5 F8	1.22e-03	5	209	2	IPR033138
Domain	Cu-oxidase_3	F5 F8	1.22e-03	5	209	2	PF07732
Domain	-	LAMC3 F5 F8 LAMC1 EPHA10	1.36e-03	73	209	5	2.60.120.260
Domain	Ion_trans_dom	RYR3 TRPM3 KCNF1 KCNH1 SCN2A KCNS1	1.79e-03	114	209	6	IPR005821
Domain	Ion_trans	RYR3 TRPM3 KCNF1 KCNH1 SCN2A KCNS1	1.79e-03	114	209	6	PF00520
Domain	Dynamin_central	DNM1 DNM2	1.81e-03	6	209	2	IPR000375
Domain	GED	DNM1 DNM2	1.81e-03	6	209	2	SM00302
Domain	Dynamin_M	DNM1 DNM2	1.81e-03	6	209	2	PF01031
Domain	GED_dom	DNM1 DNM2	1.81e-03	6	209	2	IPR020850
Domain	Cu_oxidase_Cu_BS	F5 F8	1.81e-03	6	209	2	IPR002355
Domain	GED	DNM1 DNM2	1.81e-03	6	209	2	PS51388
Domain	Dynamin_GTPase_CS	DNM1 DNM2	1.81e-03	6	209	2	IPR019762
Domain	GED	DNM1 DNM2	1.81e-03	6	209	2	PF02212
Domain	GED	DNM1 DNM2	1.81e-03	6	209	2	IPR003130
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	5.46e-10	27	165	8	M47755
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	3.04e-08	43	165	8	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	4.43e-08	45	165	8	M47670
Pathway	KEGG_SMALL_CELL_LUNG_CANCER	LAMC3 AKT1 AKT2 LAMB4 AKT3 LAMA3 LAMC1 LAMC2 PIAS1	5.76e-07	84	165	9	M3228
Pathway	WP_SMALL_CELL_LUNG_CANCER	LAMC3 DDB2 AKT1 AKT2 LAMB4 AKT3 LAMA3 LAMC1 LAMC2	1.80e-06	96	165	9	M39834
Pathway	KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.55e-05	5	165	3	M48999
Pathway	REACTOME_GLYCOGEN_SYNTHESIS	GBE1 PPP1R3C GYG1	3.07e-05	6	165	3	MM14946
Pathway	KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	3.07e-05	6	165	3	M47523
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	5.32e-05	7	165	3	M47407
Pathway	KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	5.32e-05	7	165	3	M47790
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	LAMC3 LAMB4 ITGA8 LAMA3 LAMC1 LAMC2 TNXB	5.63e-05	84	165	7	M7098
Pathway	WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION	AKT1 AKT2 AKT3 CDH2	6.12e-05	19	165	4	M39370
Pathway	BIOCARTA_LIS1_PATHWAY	DNAH8 DNAH3 DNAH2 DNAH1	6.12e-05	19	165	4	M22005
Pathway	WP_FOCAL_ADHESION	LAMC3 AKT1 AKT2 AKT3 ITGA8 LAMA3 LAMC1 LAMC2 MAPK7 TNXB	7.01e-05	187	165	10	MM15913
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47399
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47394
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47395
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47404
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47405
Pathway	KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47803
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47715
Pathway	REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M27806
Pathway	KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47482
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	8.45e-05	8	165	3	M47498
Pathway	REACTOME_MET_PROMOTES_CELL_MOTILITY	LAMC3 TNS3 LAMA3 LAMC1 LAMC2	1.10e-04	41	165	5	M27778
Pathway	KEGG_FOCAL_ADHESION	LAMC3 AKT1 AKT2 LAMB4 AKT3 ITGA8 LAMA3 LAMC1 LAMC2 TNXB	1.18e-04	199	165	10	M7253
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47397
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47392
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47391
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47402
Pathway	KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47802
Pathway	REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING	AKT1 AKT2 AKT3	1.26e-04	9	165	3	MM15666
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47490
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47481
Pathway	KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.26e-04	9	165	3	M47972
Pathway	WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR	AKT1 AKT2 AKT3 MAPK7	1.35e-04	23	165	4	MM15952
Pathway	KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.78e-04	10	165	3	M47400
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.78e-04	10	165	3	M47401
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	AKT1 AKT2 AKT3	1.78e-04	10	165	3	M27095
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS	AKT1 AKT2 AKT3	1.78e-04	10	165	3	MM14778
Pathway	KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.78e-04	10	165	3	M47615
Pathway	WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION	AKT1 AKT2 AKT3 MAPK7	1.89e-04	25	165	4	M39384
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	LAMC3 AKT1 LAMA3 LAMC1 LAMC2	1.92e-04	46	165	5	M239
Pathway	WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION	AKT1 AKT2 FOXM1 AKT3	2.21e-04	26	165	4	M48092
Pathway	KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47797
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47403
Pathway	KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47406
Pathway	KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47756
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47791
Pathway	REACTOME_GAP_JUNCTION_DEGRADATION	MYO6 DNM1 DNM2	2.42e-04	11	165	3	MM14732
Pathway	KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47484
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47499
Pathway	PID_INTEGRIN4_PATHWAY	LAMA3 LAMC1 LAMC2	2.42e-04	11	165	3	M158
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	2.42e-04	11	165	3	M47501
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M47393
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M47798
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	AKT1 AKT2 AKT3	3.21e-04	12	165	3	MM15657
Pathway	REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M27939
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	AKT1 AKT2 AKT3	3.21e-04	12	165	3	MM14777
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M47558
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M47559
Pathway	REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS	AKT1 AKT2 AKT3	3.21e-04	12	165	3	M45022
Pathway	REACTOME_GAP_JUNCTION_DEGRADATION	MYO6 DNM1 DNM2	3.21e-04	12	165	3	M15243
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	AKT1 AKT2 AKT3	3.21e-04	12	165	3	MM14550
Pathway	REACTOME_MET_ACTIVATES_PTK2_SIGNALING	LAMC3 LAMA3 LAMC1 LAMC2	3.91e-04	30	165	4	M27772
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMC3 LAMA3 LAMC1 LAMC2	3.91e-04	30	165	4	M27216
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	4.13e-04	13	165	3	M47398
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING	AKT1 AKT2 AKT3	4.13e-04	13	165	3	M549
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	4.13e-04	13	165	3	M47603
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	5.21e-04	14	165	3	M47390
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS	AKT1 AKT2 AKT3	5.21e-04	14	165	3	MM15341
Pathway	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	AKT1 AKT2 AKT3	5.21e-04	14	165	3	M3862
Pathway	WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM	AKT2 APOB MTTP	5.21e-04	14	165	3	M48059
Pathway	REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING	DNM1 DNM2 DNAL4	5.21e-04	14	165	3	M10122
Pathway	REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS	AKT1 AKT2 AKT3	5.21e-04	14	165	3	M27638
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	5.21e-04	14	165	3	M47467
Pathway	REACTOME_GLYCOGEN_SYNTHESIS	GBE1 PPP1R3C GYG1	5.21e-04	14	165	3	M27247
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	5.21e-04	14	165	3	M47536
Pathway	WP_FOCAL_ADHESION	LAMC3 AKT1 AKT2 AKT3 ITGA8 LAMA3 LAMC1 LAMC2 TNXB	5.59e-04	199	165	9	M39402
Pathway	WP_ALPHA_6_BETA_4_SIGNALING	AKT1 LAMA3 LAMC1 LAMC2	5.68e-04	33	165	4	M39503
Pathway	WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS	AKT1 AKT2 FOXM1 AKT3	6.38e-04	34	165	4	M48081
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M47389
Pathway	KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M47663
Pathway	REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M26902
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M47475
Pathway	WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M48306
Pathway	KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	6.46e-04	15	165	3	M47971
Pathway	PID_PI3KCI_AKT_PATHWAY	AKT1 AKT2 AKT3 PRKDC	7.14e-04	35	165	4	M249
Pathway	REACTOME_GLYCOGEN_STORAGE_DISEASES	GBE1 PPP1R3C GYG1	7.88e-04	16	165	3	M27236
Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	PIP5K1B AKT1 AKT2 DNM1 DNM2 AKT3	9.13e-04	96	165	6	M16121
Pathway	SA_PTEN_PATHWAY	AKT1 AKT2 AKT3	9.49e-04	17	165	3	M12771
Pathway	SA_TRKA_RECEPTOR	AKT1 AKT2 AKT3	9.49e-04	17	165	3	M18895
Pathway	WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES	AKT1 AKT2 AKT3	9.49e-04	17	165	3	M48086
Pathway	REACTOME_GLYCOGEN_METABOLISM	GBE1 PPP1R3C GYG1	1.13e-03	18	165	3	MM15577
Pathway	KEGG_PHENYLALANINE_METABOLISM	ALDH3B2 IL4I1 PAH	1.13e-03	18	165	3	M16650
Pathway	KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY	AKT1 AKT2 AKT3	1.33e-03	19	165	3	M47525
Pathway	REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT	ABCB1 ABCG2	1.33e-03	5	165	2	M27147
Pathway	BIOCARTA_MRP_PATHWAY	ABCB1 ABCC1	1.33e-03	5	165	2	MM1586
Pathway	REACTOME_VLDL_ASSEMBLY	APOB MTTP	1.33e-03	5	165	2	M27760
Pathway	REACTOME_VLDL_ASSEMBLY	APOB MTTP	1.33e-03	5	165	2	MM15505
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAH12	1.00e-12	14	214	7	9373155
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH8 DNAH3 DNAH2 DNAH1 DNAH12	1.75e-10	7	214	5	9256245
Pubmed	A new nomenclature for the laminins.	LAMC3 LAMA3 LAMC1 LAMC2	4.81e-08	7	214	4	7921537
Pubmed	Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53.	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	6.76e-08	18	214	5	11311202
Pubmed	DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA.	AKT1 AKT2 AKT3 PRKDC	1.71e-07	9	214	4	15678105
Pubmed	Deletion of PKBalpha/Akt1 affects thymic development.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	17912369
Pubmed	Differential prognostic values of the three AKT isoforms in acute myeloid leukemia.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	38528080
Pubmed	Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	15987444
Pubmed	Imaging of activity of multidrug resistance-associated protein 1 in the lungs.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	23596979
Pubmed	Kinetic mechanism of AKT/PKB enzyme family.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	16540465
Pubmed	ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	22545122
Pubmed	A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	29342177
Pubmed	All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	38396845
Pubmed	AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	29173281
Pubmed	Akt/PKB isoforms expression in the human lumbar herniated disc: correlation with clinical and MRI findings.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	21590431
Pubmed	Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT's Role in Complex Brain Disorders and Neurological Disease.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	34296180
Pubmed	Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	27689338
Pubmed	Opposing functions of Akt isoforms in lung tumor initiation and progression.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	24722238
Pubmed	ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	19165709
Pubmed	Nonredundant role of Akt2 for neuroprotection of rod photoreceptor cells from light-induced cell death.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	17202487
Pubmed	Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	23929892
Pubmed	Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	19805051
Pubmed	In vivo analysis of protein kinase B (PKB)/Akt regulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response and tumorigenesis.	AKT1 AKT2 PRKDC	2.30e-07	3	214	3	18757368
Pubmed	Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	33420675
Pubmed	Signalling specificity in the Akt pathway in breast cancer.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	25233414
Pubmed	Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	21555366
Pubmed	All Akt isoforms (Akt1, Akt2, Akt3) are involved in normal hearing, but only Akt2 and Akt3 are involved in auditory hair cell survival in the mammalian inner ear.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	25811375
Pubmed	Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	27098694
Pubmed	Cellular survival: a play in three Akts.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	10579998
Pubmed	Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	22182917
Pubmed	Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	21956451
Pubmed	Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	17895832
Pubmed	Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	17210696
Pubmed	Differential activation of AKT isoforms by growth factors in human myotubes.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	37879895
Pubmed	ATP-binding cassette proteins BCRP, MRP1 and P-gp expression and localization in the human umbilical cord.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	26407213
Pubmed	MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	19825827
Pubmed	Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	20102399
Pubmed	Distinct roles of the three Akt isoforms in lactogenic differentiation and involution.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	18561256
Pubmed	Differential effects of Akt isoforms on somatic cell reprogramming.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	25037569
Pubmed	Protein kinase Akt activity in human thyroid tumors.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	29235817
Pubmed	[Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	19622290
Pubmed	Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	16960658
Pubmed	Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	17982014
Pubmed	Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	17445775
Pubmed	The AKT genes and their roles in various disorders.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	24039187
Pubmed	Laminin isoforms containing the gamma3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma1 and gamma2 chains.	LAMC3 LAMC1 LAMC2	2.30e-07	3	214	3	18697739
Pubmed	Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	16923958
Pubmed	Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	26953242
Pubmed	Specific Akt Family Members Impair Stress-Mediated Transactivation of Viral Promoters and Enhance Neuronal Differentiation: Important Functions for Maintaining Latency.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	32796067
Pubmed	Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	20724596
Pubmed	Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	24382439
Pubmed	Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia.	UGGT1 ABCB1 ABCC1	2.30e-07	3	214	3	28025333
Pubmed	Variation in Akt protein kinases in human populations.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	28931550
Pubmed	Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	20398329
Pubmed	Isoform-specific roles for AKT in affective behavior, spatial memory, and extinction related to psychiatric disorders.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	33325370
Pubmed	Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	16278376
Pubmed	Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	19067785
Pubmed	The Akt isoforms are present at distinct subcellular locations.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	20018949
Pubmed	Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	24247267
Pubmed	Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	10491192
Pubmed	Expression and function of ABC-transporter protein ABCB1 correlates with inhibitory capacity of Ruxolitinib in vitro and in vivo.	ABCB1 ABCG2 ABCC1	2.30e-07	3	214	3	26589910
Pubmed	Role for Akt3/protein kinase Bgamma in attainment of normal brain size.	AKT1 AKT2 AKT3	2.30e-07	3	214	3	15713641
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMC3 LAMA3 LAMC1 LAMC2	4.45e-07	11	214	4	21524702
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	USP18 KAT2A PLXND1 TRPM3 KCNH1 KCNS1 AKT1 AKT2 ECEL1 DNM1 DNM2 AKT3 DNAH10 DNAH2 SIK3 PIAS1 ADAMTS10 MTMR6	7.34e-07	730	214	18	34857952
Pubmed	Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	18200595
Pubmed	Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	17875533
Pubmed	Akt1 deletion prevents lung tumorigenesis by mutant K-ras.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	21242979
Pubmed	Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	21881209
Pubmed	Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	19435822
Pubmed	Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	36507589
Pubmed	Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	17942896
Pubmed	Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	30567482
Pubmed	Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	21763505
Pubmed	Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	19969351
Pubmed	Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	31552693
Pubmed	Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	19933838
Pubmed	Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	26507673
Pubmed	FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	24030729
Pubmed	Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	21507933
Pubmed	Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain.	AKT1 AKT2 AKT3	9.15e-07	4	214	3	26227811
Pubmed	Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	16041239
Pubmed	Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).	ABCB1 ABCG2 ABCC1	9.15e-07	4	214	3	11986944
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ATRX MAP1B UGGT1 LPCAT4 KAT2A ABCB1 CLCN4 SACS TASOR DNAH8 TOP3B MED13 MRPL47 DNAH2 GRIA4 MYO1B APOB ZFC3H1 DHRS7B TBC1D31 CHD5 DNAJC11 MTTP CFAP74 PRKDC IL1R1	1.02e-06	1442	214	26	35575683
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMC3 LAMA3 LAMC1 LAMC2	1.80e-06	15	214	4	15895400
Pubmed	Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	9512493
Pubmed	Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	17442925
Pubmed	Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.	ABCB1 ABCG2 ABCC1	2.28e-06	5	214	3	19924384
Pubmed	Platelet-derived growth factor protects neurons against gp120-mediated toxicity.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	18300076
Pubmed	The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	36640312
Pubmed	The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	20059950
Pubmed	Akt1-Inhibitor of DNA binding2 is essential for growth cone formation and axon growth and promotes central nervous system axon regeneration.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	27938661
Pubmed	PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	26855332
Pubmed	ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	22814751
Pubmed	Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	19289493
Pubmed	The activity of the anti-apoptotic fragment generated by the caspase-3/p120 RasGAP stress-sensing module displays strict Akt isoform specificity.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	25246356
Pubmed	RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.	ABCB1 ABCG2 ABCC1	2.28e-06	5	214	3	12576456
Pubmed	Brown fat organogenesis and maintenance requires AKT1 and AKT2.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	30833219
Pubmed	Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.	AKT1 AKT2 AKT3	2.28e-06	5	214	3	26996309
Pubmed	Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development.	PTCH1 LAMA3 LAMC2 PTCH2	2.39e-06	16	214	4	12533516
Pubmed	Laminin alpha5 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through beta1 integrin signaling.	LAMC3 LAMA3 LAMC1 LAMC2	2.39e-06	16	214	4	17601529
GeneFamily	Dyneins, axonemal	DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 DNAL4 DNAH12	4.73e-13	17	152	8	536
GeneFamily	Laminin subunits	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	2.97e-08	12	152	5	626
GeneFamily	Taste 1 receptors	TAS1R3 TAS1R2	2.09e-04	3	152	2	1161
Coexpression	GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	USP18 SPATA2 ABCB1 SACS PGAP1 ECEL1 TASOR BANK1 SZT2 PEDS1	5.73e-06	200	212	10	M6991
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SYN3 ATRX MAP1B LRRK2 LPCAT4 TMEM132B SOCS7 CLCN4 SCN2A PGAP1 DNM1 NEDD4L GPR26 ITGA8 LAMA3 GRIA4 LAMC2 SIK3 CCDC141 PTPRT MTMR6 THRA CHD5 ZFHX2	1.16e-05	1106	212	24	M39071
Coexpression	NABA_BASEMENT_MEMBRANES	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	1.73e-05	40	212	5	M5887
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ATRX MAP1B GBE1 SACS XPO6 TASOR MED13 RAD51C ABCC1 AHCTF1 LAMC1 MYO1B FRYL SIK3 ELL2 TBC1D31 MICAL2 AKAP11 IL1R1 CDH2	2.31e-05	856	212	20	M4500
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	LAMA3 LAMC1 LAMC2 TNXB	3.27e-05	23	212	4	M48001
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP	LRRK2 PLXND1 PTCH1 FANCA IL4I1 GPR89B FNTB PTPRT LRRC8A	3.73e-05	199	212	9	M4063
Coexpression	GSE14308_TH17_VS_INDUCED_TREG_UP	ATRX MTA3 SACS ABCG2 DNAH8 SIK3 GYG1 RNF38 PRKDC	3.88e-05	200	212	9	M3385
Coexpression	GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN	F5 ADD1 DNM1 FNTB FRYL C6orf136 PCDH20 DNAH1 CDH2	3.88e-05	200	212	9	M3877
Coexpression	GSE339_CD4POS_VS_CD8POS_DC_UP	USP18 ABCF3 IPP PLXND1 RYR3 ABCB1 CIB1 MYO1B IL1R1	3.88e-05	200	212	9	M5108
Coexpression	GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP	USP18 GREB1L MINAR1 COL12A1 ANO1 EPB41L5 TNS2 FBXO16 MTMR6	3.88e-05	200	212	9	M7802
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 PKD1L2 RYR3 TRPM3 SCN2A COL12A1 DNAH10 APOB GRIN2B DNAH1 MYO15A EPHA10	9.92e-11	184	213	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 PKD1L2 RYR3 TRPM3 SCN2A COL12A1 DNAH10 APOB GRIN2B DNAH1 MYO15A EPHA10	9.92e-11	184	213	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 PKD1L2 RYR3 TRPM3 SCN2A COL12A1 DNAH10 APOB GRIN2B DNAH1 MYO15A EPHA10	9.92e-11	184	213	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	ABCA13 RYR3 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.05e-08	191	213	10	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	ABCA13 RYR3 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.05e-08	191	213	10	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 NHSL1 MICAL2	4.49e-08	199	213	10	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 MICAL2	3.23e-07	188	213	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-07	191	213	9	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-07	191	213	9	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-07	191	213	9	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-07	191	213	9	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-07	191	213	9	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	F5 GREB1L MTA3 PIP5K1B MED13 NEDD4L EPB41L5 ELL2 PAH	4.03e-07	193	213	9	503a979328c68b096680b71359a26f02fafdff35
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 MICAL2	4.21e-07	194	213	9	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 LRRK2 TRPM3 KCNH1 SCN2A KCNS1 GPR26 PTPRT MICAL2	4.39e-07	195	213	9	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LRRK2 NAIP PLXND1 ST3GAL6 TBC1D12 TNS3 ZSWIM6 TTC7A MICAL2	4.99e-07	198	213	9	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO6 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 NHSL1 MICAL2	5.21e-07	199	213	9	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO6 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 NHSL1 MICAL2	5.21e-07	199	213	9	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO6 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 NHSL1 MICAL2	5.21e-07	199	213	9	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Control\|World / group, cell type (main and fine annotations)	MYO6 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 MICAL2	1.54e-06	168	213	8	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	1.61e-06	169	213	8	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	MYO6 ECEL1 COL12A1 NEDD4L EPB41L5 LAMA3 MYO1B OR1D2	1.68e-06	170	213	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B LAMC3 FANCA MINAR1 FOXM1 COL12A1 ANO1 MICAL2	1.75e-06	171	213	8	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B LAMC3 FANCA MINAR1 FOXM1 COL12A1 ANO1 MICAL2	1.75e-06	171	213	8	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F8 FANCA TRPM3 FOXM1 FRYL PTPRT ZFHX2 AKAP11	2.00e-06	174	213	8	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B F5 RYR3 ST3GAL6 TACR3 MRGPRF TSPEAR MYO1B	2.27e-06	177	213	8	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IPP SCN2A RAD51C DNAH10 ITGA8 TBC1D31 TTLL4 SLC38A6	2.27e-06	177	213	8	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B F5 RYR3 ST3GAL6 TACR3 MRGPRF TSPEAR MYO1B	2.37e-06	178	213	8	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma\|GI_small-bowel / Manually curated celltypes from each tissue	ST3GAL6 PIP5K1B AMPD1 TAS1R3 CCDC110 ITGA8 LAMC1 FBXO16	2.68e-06	181	213	8	9b33f531c8ac776706ec7e2d47e95ba30b6ce13c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA13 LRRK2 PIP5K1B AKT2 TNS3 COL12A1 GTF2IRD1 CDH2	2.68e-06	181	213	8	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	10x5'-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells\|GI_small-bowel / Manually curated celltypes from each tissue	ST3GAL6 PIP5K1B AMPD1 TAS1R3 CCDC110 ITGA8 LAMC1 FBXO16	2.68e-06	181	213	8	a0549a8c2b5b30e91fae3052f398e48baa45d7ff
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	2.79e-06	182	213	8	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.03e-06	184	213	8	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.15e-06	185	213	8	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 ZFHX2 CFAP74	3.15e-06	185	213	8	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.28e-06	186	213	8	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCB1 GREB1L TRPM3 SCN2A AKT3 NEDD4L MYO1B GRIN2B	3.41e-06	187	213	8	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.55e-06	188	213	8	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.55e-06	188	213	8	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.55e-06	188	213	8	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-06	189	213	8	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	LRRK2 SACS STAMBPL1 CIB1 TAS1R3 RNF213 GYG1 GEN1	3.69e-06	189	213	8	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-06	189	213	8	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-06	189	213	8	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	mild-Myeloid-Immature_Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HK3 ABCA13 GBE1 NLRC4 MINAR1 DNAH10 HTRA3 GYG1	3.69e-06	189	213	8	94dd5d4d815449feff7ce157fe7f8234f7c81422
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-06	189	213	8	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.69e-06	189	213	8	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MAP1B DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.84e-06	190	213	8	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MAP1B ABCA13 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1B ABCA13 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1B ABCA13 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	c4b223b33c020a064f576711a3d700eb60a2d737
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B CCDC141 MICAL2	3.99e-06	191	213	8	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	Control-Epithelial-Ciliated\|Control / Disease group,lineage and cell class （2021.01.30）	MAP1B ABCA13 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MAP1B ABCA13 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	b4e335e798c9617356b8e24412f9270c42dce656
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	3.99e-06	191	213	8	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B MICAL2	4.15e-06	192	213	8	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO6 LRRK2 PIP5K1B DNM2 NEDD4L EPB41L5 LAMA3 CCDC141	4.15e-06	192	213	8	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 LRRK2 PLXND1 TRPM3 KCNS1 GPR26 LAMA3 PTPRT	4.15e-06	192	213	8	25460ca9ebd3d49f666394cf99ab77a5e8f77250
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B MICAL2	4.15e-06	192	213	8	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	4.31e-06	193	213	8	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNF1 SCN2A KCNS1 DNM1 GPR26 GRIN2B CHD5 EPHA10	4.31e-06	193	213	8	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNF1 SCN2A KCNS1 DNM1 GPR26 GRIN2B CHD5 EPHA10	4.31e-06	193	213	8	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	4.48e-06	194	213	8	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 LRRK2 PIP5K1B NEDD4L EPB41L5 LAMA3 MYO1B MICAL2	4.65e-06	195	213	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B TMEM132B KCNH1 SCN2A DNM1 GRIN2B MICAL2 CHD5	4.83e-06	196	213	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	MAP1B RPS9 NAIP PGAP1 NEDD4L DNAH10 ZSWIM6 NHSL1	4.83e-06	196	213	8	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B PTCH1 KCNF1 DNM1 AKT3 ITGA8 HTRA3 TNXB	5.01e-06	197	213	8	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMC3 TNS3 MRGPRF ANO1 TNS2 LAMC1 HTRA3 MYO1B	5.01e-06	197	213	8	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 ZFHX2 CFAP74	5.01e-06	197	213	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ECEL1 DNM2 LARGE2 CCDC110 LAMA3 LAMC2 CCDC141 MTTP	5.01e-06	197	213	8	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	ABCA13 DNAH3 DNAH10 DNAH2 LAMC2 DNAH7 PTPRT DNAH12	5.01e-06	197	213	8	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	5.60e-06	200	213	8	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	distal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH3 DNAH2 LAMC2 DNAH7 PTPRT DNAH12 MTTP CFAP74	5.60e-06	200	213	8	f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRRK2 DNM1 AKT3 COL12A1 ITGA8 LAMC1 HTRA3 TNXB	5.60e-06	200	213	8	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	5.60e-06	200	213	8	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Sigmoid-(1)_T_cell-(18)_cycling_gd_T\|Sigmoid / shred on region, Cell_type, and subtype	ZNF587B XPO6 FOXM1 PKD1L3 TUBGCP6 TBC1D31 MICAL2 GEN1	5.60e-06	200	213	8	6e367abd1a4b87e20eb9095b8337723163e8bbae
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	5.60e-06	200	213	8	918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCell	Sigmoid-T_cell-cycling_gd_T\|Sigmoid / Region, Cell class and subclass	ZNF587B XPO6 FOXM1 PKD1L3 TUBGCP6 TBC1D31 MICAL2 GEN1	5.60e-06	200	213	8	9769185abae084ffac36420c749625e679b70ca8
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	5.60e-06	200	213	8	ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Ciliated\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ABCA13 DNAH3 DNAH10 DNAH2 DNAH7 PTPRT DNAH12 CFAP74	5.60e-06	200	213	8	a521cf837cadf280505ff9d7e641a205af7d6513
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 DNAH3 NEDD4L DNAH10 DNAH7 PTPRT DNAH12	8.37e-06	151	213	7	8216462e723fec2797387929dde095370947e10a
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 NLRC4 GREB1L STAMBPL1 NOCT ST6GALNAC2 GEN1	8.74e-06	152	213	7	b61d2f6ee819c8dd4b4b601a8bc8388b1983de58
ToppCell	P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PGAP1 ANO1 LAMA3 LAMC2 DNAH1 KLHDC8A CERS3	9.12e-06	153	213	7	5501095bcf73080872ae01128f21399f9cfc5dd1
ToppCell	droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F5 APOA5 PM20D1 MYO1B APOB PCDH20 PPP1R3C	9.52e-06	154	213	7	a5289000597068ee8d559f89bce7bce31f35dd57
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	ABCA13 DNAH10 LAMC2 CCDC141 PTPRT DNAH12 FAM83A	1.04e-05	156	213	7	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 ABCA13 F5 NWD2 TACR3 DNAH10 GRIN2B	1.32e-05	162	213	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRRC14B TRPM3 DNAH2 LAMA3 LAMC2 ZFHX2	1.34e-05	108	213	6	d620f07243c2628494e689bbfabc14c453f4b1f4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LARGE2 ANO1 EPB41L5 LAMA3 LAMC2 KLHDC8A CERS3	1.61e-05	167	213	7	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LARGE2 ANO1 EPB41L5 LAMA3 LAMC2 KLHDC8A CERS3	1.61e-05	167	213	7	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR89B TAS1R3 MYO1B GRIN2B PTPRT CERS3 ZFHX2	1.67e-05	168	213	7	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRRK2 ALMS1 TRPM3 HERC3 STAMBPL1 FOXM1 ST6GALNAC2	1.67e-05	168	213	7	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--\|Striatum / BrainAtlas - Mouse McCarroll V32	GBE1 GMIP KCNS1 SGO2 SLC9A8 CFAP74 SMAD9	1.74e-05	169	213	7	5375eb52ebadccb7bfff997a11985f23e81014d6
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 USP18 MAP1B LAMC3 STAMBPL1 COL12A1 TBX4	1.74e-05	169	213	7	58098f8801ca941aeddafb47e88ab0df8b9edb57
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)\|Striatum / BrainAtlas - Mouse McCarroll V32	GBE1 GMIP KCNS1 SGO2 SLC9A8 CFAP74 SMAD9	1.74e-05	169	213	7	c3bf0cb67f200d02d5a021754e9b2a68d23ea168
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1B PGAP1 DNAH10 PTPRT DNAH1 FBXO16 DNAH12	1.74e-05	169	213	7	8bca402e144819cb9a8d431d6bf9429be2fff6d6
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ADCY10 USP18 MAP1B LAMC3 STAMBPL1 COL12A1 TBX4	1.74e-05	169	213	7	1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PGAP1 DNAH3 DNAH10 DNAH7 DNAH1 DNAH12 CFAP74	1.74e-05	169	213	7	fba841664939c771881ba97f14ef1df6635c04ff
Drug	AC1L1G72	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	3.09e-08	11	214	5	CID000003553
Drug	taxane	ABCB1 ABCG2 ABCC1	8.19e-07	3	214	3	ctd:C080625
Drug	ZINC03993519	ABCB1 AKT1 ABCG2 TOP3B ABCC1	1.62e-06	22	214	5	CID006440178
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; HL60; HT_HG-U133A	DIMT1 KCNS1 AKT2 LAMB4 ITGA8 TNS2 MYO1B LAMC2 MICAL2 TTLL4 CDH2	2.78e-06	197	214	11	2362_UP
Drug	AC1L1KMJ	MYO6 LAMC3 ADD1 SACS AKT1 NOCT DNM1 DNM2 LAMB4 COL12A1 LAMA3 LAMC1 MYO1B LAMC2 MAPK7 MYO15A CDH2	2.90e-06	476	214	17	CID000030956
Drug	taxol	MAP1B NAIP LAMC3 ABCB1 AKT1 AKT2 ABCG2 TOP3B FOXM1 ABCC1 LAMB4 LAMA3 LAMC1 LAMC2 PKD1L3 FBXO16 CYP4F12 SLC38A6	6.36e-06	560	214	18	CID000004666
Drug	AC1L1B58	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	6.92e-06	29	214	5	CID000001288
Drug	NSC671054	ABCB1 ABCG2 ABCC1	8.08e-06	5	214	3	CID005357223
Drug	Cyclosporins	ABCB1 ABCG2 ABCC1	8.08e-06	5	214	3	ctd:D003524
Drug	Novobiocin	AKT1 ABCG2 CDH2	8.08e-06	5	214	3	ctd:D009675
Drug	potassium	GABRR2 BCKDK PTCH1 F5 ADD1 RYR3 CLCN4 SACS KCNF1 KCNH1 SCN2A KCNS1 AKT1 AKT2 ABCG2 FOXM1 GPR89B AKT3 NEDD4L MYO1B GRIN2B PKD1L3 LGALS3BP MTMR6 GYG1	9.85e-06	1008	214	25	CID000000813
Drug	Methyl-1 (S-methylphosphoryl-3) imidazolium	F8 FANCA APOA5 LAMC1 LAMC2 APOB OR1D2 PAH SLC38A6	1.35e-05	151	214	9	CID000051213
Drug	bisbenzimide ethoxide trihydrochloride	ABCB1 ABCG2 ABCC1	1.60e-05	6	214	3	ctd:C017807
Drug	pyropheophorbide-a methyl ester	ABCB1 ABCG2 ABCC1	1.60e-05	6	214	3	CID005476777
Drug	Cefpiramide acid	ABCB1 ABCG2 ABCC1	1.60e-05	6	214	3	CID000002642
Drug	laniquidar	ABCB1 ABCG2 ABCC1	1.60e-05	6	214	3	CID006450806
Drug	Calcort	LAMC3 LAMB4 LAMA3 LAMC1 LAMC2	2.73e-05	38	214	5	CID000026709
Drug	CL-387,785	ABCB1 AKT1 ABCG2 ABCC1	3.27e-05	20	214	4	CID000002776
Drug	diosmin	GBE1 ABCB1 ABCG2 ABCC1	4.01e-05	21	214	4	CID005281613
Drug	AC1O0B8G	LAMC3 PTCH1 AKT1 ABCG2 FOXM1 ABCC1 LAMB4 LAMA3 LAMC1 LAMC2 IL1R1	4.05e-05	262	214	11	CID000091605
Drug	OC144-093	ABCB1 ABCG2 ABCC1	4.43e-05	8	214	3	CID006450807
Drug	carbamazepine	PTCH1 ABCB1 SCN2A ABCG2 IL4I1 APOA5 TSPEAR APOB GRIN2B	5.17e-05	179	214	9	CID000002554
Drug	4'-methoxy-1-naphthylfenoterol	ABCB1 ABCG2 ABCC1	6.60e-05	9	214	3	ctd:C000603500
Drug	IAARh123	ABCB1 ABCG2 ABCC1	6.60e-05	9	214	3	CID000656577
Drug	MS-209	ABCB1 ABCG2 ABCC1	6.60e-05	9	214	3	CID000213040
Drug	terpinolene	ABCB1 KCNH1 ABCG2	6.60e-05	9	214	3	CID000011463
Drug	Akt inhibitor IV	ABCB1 AKT1 AKT2 AKT3	6.96e-05	24	214	4	CID002326992
Drug	Epirubicin	ABCB1 AKT1 ABCG2 ABCC1 THRA	7.79e-05	47	214	5	ctd:D015251
Drug	pU-2	APOB GRIN2B CARD8 PAH	8.22e-05	25	214	4	CID000448973
Drug	azidoprazosin	ABCB1 ABCG2	8.79e-05	2	214	2	ctd:C041552
Drug	1,6-dichlorosucrose	TAS1R3 TAS1R2	8.79e-05	2	214	2	ctd:C039464
Drug	1-chlorosucrose	TAS1R3 TAS1R2	8.79e-05	2	214	2	ctd:C039463
Drug	4-hydroxybutyl acrylate	F8 SCN2A	8.79e-05	2	214	2	CID000075588
Drug	AC1NTFJE	ABCB1 ABCG2	8.79e-05	2	214	2	CID005380052
Drug	neotame	TAS1R3 TAS1R2	8.79e-05	2	214	2	ctd:C404525
Drug	sipholenol A	ABCB1 ABCG2	8.79e-05	2	214	2	CID000342374
Drug	tryptoquivaline	ABCB1 ABCG2	8.79e-05	2	214	2	ctd:C010522
Drug	zosuquidar trihydrochloride	ABCB1 ABCG2	8.79e-05	2	214	2	ctd:C095179
Drug	AC1L1ICP	NOCT APOB GRIN2B	9.36e-05	10	214	3	CID000004520
Drug	DiOC2(3	ABCB1 ABCG2 ABCC1	9.36e-05	10	214	3	CID000092848
Drug	Edotecarinum	ABCB1 ABCG2 TOP3B	9.36e-05	10	214	3	CID000151078
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PTCH1 KCNH1 HERC3 DNM2 ITGA8 MYO1B OR1D2 DNAL4 TTLL4	1.04e-04	196	214	9	1481_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	SYN3 KAT2A GREB1L LAMB4 AKT3 NEDD4L ITGA8 OR1D2 CYP4F12	1.04e-04	196	214	9	4767_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	PLXND1 FANCA HERC3 GPD2 ABCC1 NEDD4L DNAH7 DNAL4 THRA	1.04e-04	196	214	9	6708_DN
Drug	Felodipine [72509-76-3]; Up 200; 10.4uM; HL60; HT_HG-U133A	GABRR2 MYO6 KCNH1 KCNS1 ZFHX2 MAPK7 MYO15A IL1R1 CDH2	1.08e-04	197	214	9	2433_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	ABCF3 MAP1B IPP DIMT1 ALMS1 TNS2 PPP1R3C DNAL4 RCL1	1.08e-04	197	214	9	5815_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KCNS1 HERC3 TOP3B AKT3 LAMC2 VPS13D TTLL4 MAPK7 MYO15A	1.08e-04	197	214	9	6011_UP
Drug	lamotrigine	PTCH1 RYR3 ABCB1 SCN2A GRIA4 GRIN2B PKD1L3	1.15e-04	116	214	7	CID000003878
Drug	I-Q-S	MYO6 LAMC3 LAMB4 LAMA3 LAMC1 LAMC2 PAH AKAP11	1.18e-04	156	214	8	CID000003540
Drug	antineutrophil cytoplasmic antibody	ABCB1 CLCN4 SACS ABCG2 TOP3B	1.27e-04	52	214	5	CID000002201
Drug	BM165	LAMA3 LAMC1 LAMC2	1.28e-04	11	214	3	CID003352881
Drug	magnesium	GABRR2 HK3 BCKDK LAMC3 GAL3ST2 RYR3 ABCB1 TRPM3 KCNH1 NOCT DNM1 DNAH8 TOP3B FOXM1 RAD51C ABCC1 LAMB4 DNAH3 DNAH10 FNTB LAMA3 LAMC1 GRIA4 MYO1B LAMC2 GRIN2B DNAH1	1.29e-04	1325	214	27	CID000000888
Drug	fumitremorgin C	ABCB1 AKT1 ABCG2 ABCC1	1.30e-04	28	214	4	CID000403923
Drug	2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine	LAMC3 F8 LAMB4 LAMA3 LAMC1 LAMC2	1.33e-04	83	214	6	CID011968896
Disease	Colorectal Carcinoma	HK3 MAP1B ABCA13 SF3A1 IPP F5 ABCB1 SACS AKT1 ABCG2 DNAH8 ABCC1 AMPD1 DNAH3 TSPEAR LAMC1 MYO1B APOB PTPRT CHD5 SMAD9	2.82e-08	702	207	21	C0009402
Disease	chronic myeloid leukemia (is_implicated_in)	HLA-DQA1 ABCB1 AKT1 ABCG2	1.28e-05	21	207	4	DOID:8552 (is_implicated_in)
Disease	malignant astrocytoma (is_marker_for)	ATRX AKT1 AKT2 AKT3	1.88e-05	23	207	4	DOID:3069 (is_marker_for)
Disease	Epilepsy, Cryptogenic	ABCB1 KCNH1 SCN2A AKT1 DNM1 GRIN2B	2.49e-05	82	207	6	C0086237
Disease	Awakening Epilepsy	ABCB1 KCNH1 SCN2A AKT1 DNM1 GRIN2B	2.49e-05	82	207	6	C0751111
Disease	Aura	ABCB1 KCNH1 SCN2A AKT1 DNM1 GRIN2B	2.49e-05	82	207	6	C0236018
Disease	ovarian cancer (is_implicated_in)	MYO6 FANCA AKT1 ITGA8 APOB	4.62e-05	56	207	5	DOID:2394 (is_implicated_in)
Disease	laminin subunit gamma-2 measurement	LAMC1 LAMC2	4.90e-05	2	207	2	EFO_0801756
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	MAP1B GREB1L EPHA10	5.39e-05	11	207	3	DOID:0050564 (is_implicated_in)
Disease	Epileptic encephalopathy	RYR3 DNM1 NEDD4L GRIN2B	5.59e-05	30	207	4	C0543888
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-DQA1 BANK1 DNAH10 APOA5 APOB SIK3 DNAH1 MTTP	8.94e-05	200	207	8	EFO_0004611, EFO_0020945
Disease	type 2 diabetes mellitus (implicated_via_orthology)	ALMS1 AKT1 AKT2 FOXM1 AKT3 PPP1R3C	1.00e-04	105	207	6	DOID:9352 (implicated_via_orthology)
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-DQA1 DDB2 BANK1 DNAH10 APOA5 APOB SIK3 DNAH1	1.10e-04	206	207	8	EFO_0004612, EFO_0020947
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQA1 BANK1 APOA5 APOB SIK3	1.10e-04	67	207	5	EFO_0008595, EFO_0020946
Disease	triglycerides to phosphoglycerides ratio	HLA-DQA1 BANK1 DNAH10 APOB SIK3	1.18e-04	68	207	5	EFO_0022327
Disease	Epilepsy	ABCB1 KCNH1 SCN2A AKT1 DNM1 GRIN2B	1.23e-04	109	207	6	C0014544
Disease	Parkinson's disease (implicated_via_orthology)	PTCH1 PITX3 AKT1 AKT2 AKT3 HTRA3 PTCH2	1.27e-04	157	207	7	DOID:14330 (implicated_via_orthology)
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3 MTTP	1.30e-04	110	207	6	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3 MTTP	1.30e-04	110	207	6	EFO_0004574, EFO_0008317, EFO_0008596
Disease	Junctional epidermolysis bullosa	LAMA3 LAMC2	1.46e-04	3	207	2	cv:C0079301
Disease	neuromyelitis optica	HLA-DQA1 TNXB	1.46e-04	3	207	2	EFO_0004256
Disease	Junctional epidermolysis bullosa gravis of Herlitz	LAMA3 LAMC2	1.46e-04	3	207	2	cv:C0079683
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE	LAMA3 LAMC2	1.46e-04	3	207	2	226700
Disease	BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1	PTCH1 PTCH2	2.91e-04	4	207	2	605462
Disease	Oculo-dento-digital syndrome	PTCH1 PTCH2	2.91e-04	4	207	2	C0812437
Disease	renal agenesis (is_implicated_in)	GREB1L ITGA8	2.91e-04	4	207	2	DOID:14766 (is_implicated_in)
Disease	AQP4-IgG-positive neuromyelitis optica	HLA-DQA1 TNXB	2.91e-04	4	207	2	EFO_0009584
Disease	Herlitz Disease	LAMA3 LAMC2	2.91e-04	4	207	2	C0079683
Disease	Basal cell carcinoma, susceptibility to, 1	PTCH1 PTCH2	2.91e-04	4	207	2	cv:C2751544
Disease	Epidermolysis Bullosa Progressiva	LAMA3 LAMC2	2.91e-04	4	207	2	C0079297
Disease	Hypertriglyceridemia	APOA5 LAMC1 LAMC2	3.03e-04	19	207	3	EFO_0004211
Disease	sexual dimorphism measurement	DIS3L2 SYN3 RPS9 PTCH1 ALDH3B2 TASOR BANK1 FOXM1 TBX4 DNAH10 FNTB APOA5 MRGPRF APOB FRYL SIK3 GTF2IRD1 PKD1L3 ADAMTS10	3.15e-04	1106	207	19	EFO_0021796
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-DQA1 DDB2 DNAH10 APOA5 APOB SIK3 DNAH1 MTTP	3.37e-04	243	207	8	EFO_0004612, EFO_0020944
Disease	prostate adenocarcinoma (is_implicated_in)	AKT1 AKT2 AKT3	3.55e-04	20	207	3	DOID:2526 (is_implicated_in)
Disease	glioma	AKT3 GRIA4 CYP4F12	4.75e-04	22	207	3	EFO_0005543
Disease	EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)	LAMA3 LAMC2	4.83e-04	5	207	2	C2608084
Disease	centronuclear myopathy 1 (implicated_via_orthology)	DNM1 DNM2	4.83e-04	5	207	2	DOID:0111223 (implicated_via_orthology)
Disease	microcytic anemia (implicated_via_orthology)	DNM1 DNM2	4.83e-04	5	207	2	DOID:11252 (implicated_via_orthology)
Disease	Basal Cell Nevus Syndrome	PTCH1 PTCH2	4.83e-04	5	207	2	C0004779
Disease	Adult junctional epidermolysis bullosa (disorder)	LAMA3 LAMC2	4.83e-04	5	207	2	C0268374
Disease	Congenital absence of kidneys syndrome	GREB1L ITGA8	4.83e-04	5	207	2	C1609433
Disease	Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology)	DNM1 DNM2	4.83e-04	5	207	2	DOID:0110197 (implicated_via_orthology)
Disease	junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology)	LAMA3 LAMC2	4.83e-04	5	207	2	DOID:0060738 (implicated_via_orthology)
Disease	Squamous cell carcinoma of the head and neck	ABCB1 AKT1 ABCG2 ABCC1	4.89e-04	52	207	4	C1168401
Disease	triglycerides in HDL measurement	HLA-DQA1 APOA5 APOB SIK3	5.26e-04	53	207	4	EFO_0022317
Disease	blood zinc measurement	SYN3 GBE1 MTMR6	5.43e-04	23	207	3	EFO_0007584
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3	5.62e-04	95	207	5	EFO_0004529, EFO_0008317, EFO_0008596
Disease	triglycerides in medium HDL measurement	HLA-DQA1 APOA5 APOB SIK3	5.65e-04	54	207	4	EFO_0022321
Disease	triglyceride measurement, phospholipid measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3 DNAH1	5.95e-04	146	207	6	EFO_0004530, EFO_0004639
Disease	triglycerides in medium VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	6.06e-04	55	207	4	EFO_0022155
Disease	triglycerides in very large HDL measurement	HLA-DQA1 APOA5 APOB SIK3	6.06e-04	55	207	4	EFO_0022324
Disease	systemic scleroderma (is_implicated_in)	HLA-DQA1 BANK1 IL1R1	6.18e-04	24	207	3	DOID:418 (is_implicated_in)
Disease	triglycerides in large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	6.50e-04	56	207	4	EFO_0022178
Disease	diabetic nephropathy	GABRR2 DIS3L2 HLA-DQA1 RYR3 LAMC1 TBC1D31	6.86e-04	150	207	6	EFO_0000401
Disease	body mass index, vital capacity	DIS3L2 HLA-DQA1	7.21e-04	6	207	2	EFO_0004312, EFO_0004340
Disease	Junctional Epidermolysis Bullosa	LAMA3 LAMC2	7.21e-04	6	207	2	C0079301
Disease	periventricular nodular heterotopia (is_implicated_in)	MAP1B NEDD4L	7.21e-04	6	207	2	DOID:0050454 (is_implicated_in)
Disease	primary ciliary dyskinesia (is_implicated_in)	DNAH7 CFAP74	7.21e-04	6	207	2	DOID:9562 (is_implicated_in)
Disease	glutamate receptor 4 measurement	HLA-DQA1 TNXB	7.21e-04	6	207	2	EFO_0801630
Disease	toxic encephalopathy (is_implicated_in)	ABCB1 ABCG2	7.21e-04	6	207	2	DOID:3602 (is_implicated_in)
Disease	autism spectrum disorder (implicated_via_orthology)	SYN3 BCKDK LAMC3 SCN2A LAMC1 LAMC2	7.35e-04	152	207	6	DOID:0060041 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-DQA1 DDB2 DNAH10 APOA5 APOB SIK3 DNAH1 MTTP	7.79e-04	276	207	8	EFO_0004612, EFO_0020943
Disease	Colorectal Neoplasms	ABCA13 IPP ABCB1 AKT1 ABCG2 ABCC1 CHD5 SMAD9	7.97e-04	277	207	8	C0009404
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	HLA-DQA1 BANK1 APOA5 APOB SIK3	8.12e-04	103	207	5	EFO_0008595, EFO_0020944
Disease	cholesterol to total lipids in medium HDL percentage	HLA-DQA1 DDB2 APOB SIK3	8.44e-04	60	207	4	EFO_0022237
Disease	triglycerides in small VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	8.98e-04	61	207	4	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	8.98e-04	61	207	4	EFO_0022274
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3	9.24e-04	106	207	5	EFO_0008317, EFO_0008596
Disease	phospholipids in large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	9.55e-04	62	207	4	EFO_0022169
Disease	total lipids in very large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	9.55e-04	62	207	4	EFO_0022313
Disease	phospholipids in very large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	9.55e-04	62	207	4	EFO_0022299
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3	9.64e-04	107	207	5	EFO_0004614, EFO_0004615
Disease	lung small cell carcinoma (is_implicated_in)	ATRX LAMA3 LAMC2	9.79e-04	28	207	3	DOID:5409 (is_implicated_in)
Disease	Abnormality of the eye	MED13 CDH2	1.00e-03	7	207	2	C4316870
Disease	centronuclear myopathy (implicated_via_orthology)	DNM2 MTMR6	1.00e-03	7	207	2	DOID:14717 (implicated_via_orthology)
Disease	tumor necrosis factor receptor superfamily member 6 measurement	HLA-DQA1 STAMBPL1	1.00e-03	7	207	2	EFO_0010610
Disease	LDL cholesterol change measurement	APOB PKD1L3	1.00e-03	7	207	2	EFO_0007804
Disease	junctional epidermolysis bullosa (is_implicated_in)	LAMA3 LAMC2	1.00e-03	7	207	2	DOID:3209 (is_implicated_in)
Disease	Constipation	MED13 THRA	1.00e-03	7	207	2	C0009806
Disease	laurylcarnitine measurement	ABCB1 ABCC1	1.00e-03	7	207	2	EFO_0021041
Disease	Periventricular Nodular Heterotopia	MAP1B NEDD4L	1.00e-03	7	207	2	C1868720
Disease	apolipoprotein A 1 measurement	HLA-DQA1 DDB2 XPO6 ZNF483 AKT1 BANK1 AKT3 DNAH10 APOA5 LAMC1 APOB SIK3 PKD1L3 AGBL3 MTTP	1.01e-03	848	207	15	EFO_0004614
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	HLA-DQA1 DNAH10 APOA5 APOB SIK3	1.09e-03	110	207	5	EFO_0008317, EFO_0008596, EFO_0010351
Disease	serum metabolite measurement	IPP LAMC3 PKD1L2 NWD2 ALMS1 ABCG2 NOCT ALDH3B2 GPD2 ABCC1 LAMB4 APOA5 APOB PTPRT PAH EPHA10	1.09e-03	945	207	16	EFO_0005653
Disease	triglyceride measurement, intermediate density lipoprotein measurement	HLA-DQA1 DNAH10 APOA5 APOB MTTP	1.14e-03	111	207	5	EFO_0004530, EFO_0008595
Disease	susceptibility to cold sores measurement	AKT3 ANO1 MICAL2 TNXB	1.14e-03	65	207	4	EFO_0008402
Disease	cholesterol in large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	1.14e-03	65	207	4	EFO_0021902
Disease	cholesterol in very large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	1.14e-03	65	207	4	EFO_0022230
Disease	total lipids in small VLDL	HLA-DQA1 DNAH10 APOB SIK3	1.28e-03	67	207	4	EFO_0022148
Disease	total lipids in large VLDL	HLA-DQA1 DNAH10 APOB SIK3	1.28e-03	67	207	4	EFO_0022175
Disease	Familial pulmonary arterial hypertension	TBX4 SMAD9	1.33e-03	8	207	2	C1701939
Disease	familial hyperlipidemia (is_implicated_in)	ABCB1 APOB	1.33e-03	8	207	2	DOID:1168 (is_implicated_in)
Disease	Autistic behavior	TRPM3 MED13	1.33e-03	8	207	2	C0856975
Disease	X-17676 measurement	DNAH3 TAS1R2	1.33e-03	8	207	2	EFO_0800785
Disease	gdnf family receptor alpha-1 measurement	HLA-DQA1 TNXB	1.33e-03	8	207	2	EFO_0020400
Disease	free cholesterol in large VLDL measurement	HLA-DQA1 DNAH10 APOB SIK3	1.35e-03	68	207	4	EFO_0022265
Disease	type 2 diabetes mellitus (is_implicated_in)	HLA-DQA1 ABCB1 AKT2 GPD2 APOA5 APOB	1.35e-03	171	207	6	DOID:9352 (is_implicated_in)
Disease	renal cell carcinoma (is_implicated_in)	ABCB1 ABCG2 AKT3 THRA	1.42e-03	69	207	4	DOID:4450 (is_implicated_in)
Disease	cholesteryl esters to total lipids in very small VLDL percentage	HLA-DQA1 BANK1 APOB SIK3	1.58e-03	71	207	4	EFO_0022259
Disease	sensorineural hearing loss (is_implicated_in)	MYO6 F5 MYO15A	1.59e-03	33	207	3	DOID:10003 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSKLFLHFKSYSLTP	TBC1D12	646	O60347
EHRNTFKLNTIIYSP	nan	436	A8MVM7
YFEVNIPTDLRAKHS	BANK1	161	Q8NDB2
QYFFDHPESLSLLRS	NAIP	901	Q13075
RHPFLTALKYSFQTH	AKT1	206	P31749
NTRHPFLTALKYAFQ	AKT2	206	P31751
EKARLHASSPYFTFT	FAM228A	96	Q86W67
REFIKLHYLSPSREF	EDDM3A	31	Q14507
YQLTVRPDLFTNKHT	AGBL3	191	Q8NEM8
RQELPKLFLQSHDYS	C6orf136	156	Q5SQH8
ALETYQSHKNLIPFR	ELL2	41	O00472
LTRSPLKSTHFLFLF	CD300LD	156	Q6UXZ3
HTLTNYKAFSQFLRP	CHD5	156	Q8TDI0
FAKFTFEYSRRHPDL	AFM	351	P43652
TPETLQKHQRFYSSL	ASB10	401	Q8WXI3
YDPKHVIFSRLSVSA	ABCF3	501	Q9NUQ8
SIHQPRYSIFKLFDS	ABCG2	241	Q9UNQ0
VPSSAYSHREKLLVF	ALMS1	806	Q8TCU4
LLDTILHSPNKDFYA	ABCA13	2426	Q86UQ4
PKFSSRYQKSRIFHL	AKAP11	1621	Q9UKA4
RFKELFHPYAESLVS	APOA5	186	Q6Q788
RIYDVFRSKNFLPHF	AMPD1	461	P23109
YPFLDVKDEFTHRTL	CLCN4	581	P51793
LEHKLDYIFFTGSPR	ALDH3B2	96	P48448
NDPSFEVHYRSLSLK	ADCY10	886	Q96PN6
LFRKYALFSPSDHRV	DIS3L2	261	Q8IYB7
HELYIRAFQKLTDFP	BCKDK	126	O14874
PEHKFIYRFVRTLFS	CCNYL1	186	Q8N7R7
SDHSFFKISYLTLLP	HLA-DQA1	166	P01909
LFYKVASPSTHFLLN	ADAMTS10	76	Q9H324
KNTRHPFLTSLKYSF	AKT3	201	Q9Y243
YKTPTFLALSQRHLN	NWD2	1616	Q9ULI1
SPYTIEFLRHLKSFF	RCL1	321	Q9Y2P8
AQVYLLPDFLSEHSK	RAD51C	221	O43502
HRLVLAASSPYFAAL	IPP	51	Q9Y573
FETLRYRFSFPHSKV	LARGE2	556	Q8N3Y3
YRFSFPHSKVELLAL	LARGE2	561	Q8N3Y3
LNFVQYKFSHLAPRE	KAT2A	236	Q92830
AHPLATLFKILASFY	LRRC8A	311	Q8IWT6
NLEFRNVHFSYPSRK	ABCB1	391	P08183
KYIPRRSFFISLGHD	PM20D1	176	Q6GTS8
ISAAAALRHPFLAKY	MAPK7	336	Q13164
SSTSYRNLPHLFLFF	PCDH20	36	Q8N6Y1
KLNRASQTYFFPIHL	DNAJC11	366	Q9NVH1
LLRFAQKHYTPSENF	OGFRL1	296	Q5TC84
SSYVLSKSRALEHFP	GPD2	191	P43304
SDPFFRHYRQLNEKL	GPN2	211	Q9H9Y4
PSLSHRFLDSKFYLL	MAP1B	26	P46821
FHVAYILIKFANSPR	LAMA3	151	Q16787
NFSLHDPLYGKLFST	LPCAT4	471	Q643R3
LEFHTVPFQLLARYK	LGALS3BP	381	Q08380
LAQDLKDLYHTPSFL	NLRC4	101	Q9NPP4
KKYLNPLYSSESHRF	MTMR6	466	Q9Y217
KDSYSHPVQLDLLFR	MYO15A	2701	Q9UKN7
PFHLYDAFISLAKTL	GMIP	636	Q9P107
ALAAERKFFLSHPSY	DNM1	251	Q05193
NSTVVDLHFPLALYK	HERC3	801	Q15034
ADYKRLQTFPLVRHS	DNAL4	11	O96015
QYHLKPSAFLKSRNS	NHSL1	1111	Q5SYE7
YTAFRLAIFLHNTSP	GRIA4	41	P48058
KAASDPFVYSLLRHQ	GPR26	286	Q8NDV2
KSRDRFSYVLPLVHS	PLXND1	971	Q9Y4D7
SHLATTALQRYDLPF	MTTP	501	P55157
SVHRPSFYADRFLKF	PIP5K1B	376	O14986
PSRKGFRHQTTKFLY	KAT14	561	Q9H8E8
PSKFHYIFNLRDLSR	DNAH8	2651	Q96JB1
FELSSRKKHSLALYP	FRYL	301	O94915
PTKSHYTFNLRDFSR	DNAH12	2086	Q6ZR08
AYKFRTHSPEALEQL	PEDS1	151	A5PLL7
QDRSPILAEVKHSFY	KCNH1	901	O95259
DLHSNKFTSFPSYLL	LRRK2	1041	Q5S007
HNLVSLYPSTFFRLL	LRRC14B	341	A6NHZ5
SHFSLQPVLDSLYSK	TUBGCP6	411	Q96RT7
LPITIIFNKFSHFYR	KCNS1	451	Q96KK3
SPRSFQKKTRHYFIA	F8	1706	P00451
LFDEEFRHLYASSKP	FAM83A	281	Q86UY5
SIRYFPSLAHLSSLK	LRRC10	201	Q5BKY1
SYPFSREKQHLFDLS	ANO1	221	Q5XXA6
EELYFHFKVPTRRTF	EPHA10	606	Q5JZY3
SFDRFLAIHNPLRYT	OR51A2	121	Q8NGJ7
SFDRFLAIHNPLRYT	OR51A4	121	Q8NGJ6
LTPQYLDAHFLVSRF	OVOS2	416	Q6IE36
DLALTFSLQYPHFLK	PACS2	91	Q86VP3
HTLDSYRILQKAAPF	DDB2	96	Q92466
ALAAERKFFLSHPAY	DNM2	251	P50570
YKLHPRFSSLVAATV	HK3	871	P52790
ASYKLFPKAIHNFRS	GREB1L	1796	Q9C091
PRLKYTHDQLFFIAF	ECEL1	701	O95672
HTFLQRKNDPYALAS	ITGA8	956	P53708
EYEFFTHLDKRSLPA	PAH	76	P00439
DQVFRFYHPELSFLK	NPHP4	1131	O75161
THAALQSLRLYPFTD	PKD1L2	2166	Q7Z442
SSLDSLHYFAAELKP	PTPRT	656	O14522
LYRFAETHNLSVALP	GAL3ST2	71	Q9H3Q3
PAKSHYTFNLRDLSK	DNAH1	2431	Q9P2D7
LNIKSPAFTDLHLRY	APOB	3976	P04114
FQKDSIYRHPSLQVL	ATRX	181	P46100
FFKHSTRQPLQTDIY	CERS3	86	Q8IU89
LHLRVKFYSSEPNNL	EPB41L5	116	Q9HCM4
LLFIFNFHPSKSYTD	GBE1	621	Q04446
HQLSSPRYKFNFIAD	HTRA3	131	P83110
TTDIRKHLPFIYNLS	GYG1	176	P46976
ETFSSHFERPYLQFK	CCDC141	1281	Q6ZP82
LVQYSRDPHTEFTLK	COL12A1	481	Q99715
PSKSHYVFNLRDFSR	DNAH3	2266	Q8TD57
SSILFLYLAHKQAPE	GPR89A	436	B7ZAQ6
SSILFLYLAHKQAPE	GPR89B	436	P0CG08
PSYKAKIRAFQHAFS	FBXO45	101	P0C2W1
QHTRLLPFAFYSLLS	FANCA	1326	O15360
LTPAFHFNILKSYIT	CYP4F12	151	Q9HCS2
PAKSHYLFNLRDFSR	DNAH7	2171	Q8WXX0
LSYRSPGEIQHFSKF	CARD8	391	Q9Y2G2
LLHYAKEFLPFLSDS	C1orf112	256	Q9NSG2
QEVFSSYKFNHLVPR	FNTB	56	P49356
HPSANRYLTLDQVFK	FOXM1	311	Q08050
PHLRNLFFRISYLTQ	GEN1	51	Q17RS7
RNLFDFTPKYRATHE	FAM47A	626	Q5JRC9
KRAFSSFVTLDNHLY	KLHDC8A	211	Q8IYD2
FSHLILTFKTFRPAA	LAMB4	126	A4D0S4
TYVRLKFHTSRPESF	LAMC1	146	P11047
LTKTYTFRLNEHPSN	LAMC2	311	Q13753
AKPYHLSTSSVFRLV	AHCTF1	1016	Q8WYP5
IPFRSAYAASKHATQ	DHRS7B	201	Q6IAN0
IPFRTTYAASKHAAL	DHRS7C	186	A6NNS2
SSDKHPTDIIRFNYL	FBXO16	221	Q8IX29
FLYSTALPNHAIREL	GTF2IRD1	256	Q9UHL9
TPSKFHYIFNLRDLS	DNAH10	2646	Q8IVF4
TKRHIFPRFYFLSND	DNAH2	1526	Q9P225
FRFYITTKLSNPHYS	DNAH2	3481	Q9P225
LSTPFHRLSALETYF	DNAH2	4071	Q9P225
FDAKRPKFLTTYHEL	SACS	3166	Q9NZJ4
LNISEIESRFYKHPF	IL1R1	296	P14778
SLRLKAKQHASFSYP	PITX3	266	O75364
RSFPLSSEHAKFLIY	CDH2	91	P19022
SSYSVQLKFLPRHSL	CFAP74	861	Q9C0B2
VDHYFDTFQPLLSRL	NOCT	196	Q9UK39
YQISSPFVFKLLLHR	DIMT1	131	Q9UNQ2
QNTHAIDKYSRLIFP	GABRR2	436	P28476
LDPLDHRNFYSKLKS	MICAL2	41	O94851
RLHYVPATKVFLSFR	IL4I1	346	Q96RQ9
SDSRLHTPVYFFLAN	OR1D2	51	P34982
RSFFNRNPSEEKLHY	MINAR1	381	Q9UPX6
KRLESVSRSPVYSHF	ABCC1	1141	P33527
SLLHLLYFPDDQKFA	PIGS	506	Q96S52
LFLSRQYESLPATHI	MTA3	91	Q9BTC8
LDSQKHIDFSLRSPY	RPS9	151	P46781
LIFLHSPKYTDSNSR	SZT2	2246	Q5T011
SFKPDFILVRQHAYS	SYN3	156	O14994
YFKALHTPTNFLLLS	TAAR5	61	O14804
PKRQRLSHSVFDYTS	RNF38	61	Q9H0F5
SDYHPKVLRFLNVAF	TBC1D31	36	Q96DN5
PSTDYLSFRSHFQKN	PPP1R3C	141	Q9UQK1
HDALKTYASLATLPF	TMEM126B	101	Q8IUX1
KTFHSQLLRPSDYVY	TMEM132B	991	Q14DG7
FIYGKRHEDTLTLFP	F5	631	P12259
FSIKRNPFSIYFLHL	MRGPRF	71	Q96AM1
TKEHAFLSAQLRYFS	PTCH2	721	Q9Y6C5
PVSKRELFSFRHLFS	PKD1L3	861	Q7Z443
TLSSFAEKHYAPFLL	PTCH1	731	Q13635
KLFHFSKESAYALPT	SLC38A6	241	Q8IZM9
LSKPAFASLLRFHQF	ST3GAL6	46	Q9Y274
HPDFISYLTERFLKS	ST6GALNAC2	276	Q9UJ37
YKDSNTLHLPTERFS	SIK3	606	Q9Y2K2
SYLLNFFRDHKITPK	SLC9A8	401	Q9Y2E8
FYTKAFRSLSEIHSP	SGO2	1131	Q562F6
ILALVSSFFYRHKDS	SLC41A3	236	Q96GZ6
EKRYIQLPVTHLFSF	PGAP1	461	Q75T13
DHAKFSPVATASYRL	POLR1C	221	O15160
IYPQHLKSLAFSAFT	MED13	1706	Q9UHV7
DQDLLHSSRFFPYTS	PIAS1	571	O75925
KLFFRRHYPVNSVIF	TNS3	1366	Q68CZ2
SYDELELKTTRFHPN	TACR3	381	P29371
KSTPNVTSFHQYRLL	MRPL47	41	Q9HD33
DFLRPQHSLFNYFTK	SF3A1	196	Q15459
RHSEYNPQLSLLAKF	SMAD9	146	O15198
KFLYSAPRNKSHIDT	TASOR	586	Q9UK61
LKFHSRVPRYTLSFL	CCDC110	371	Q8TBZ0
RVPRYTLSFLDQTKH	CCDC110	376	Q8TBZ0
FTLHSAIYAARPDVK	ADD1	221	P35611
TATPDIKSHYAFRIF	CIB1	101	Q99828
HYRVPKQTLSAAAVF	RNF213	1966	Q63HN8
TTHYPENFDLKGSLR	TOP3B	341	O95985
ASTLLSLHKVDPFYR	SPATA2	46	Q9UM82
HALFNYSISSRLSPK	TAS1R3	281	Q7RTX0
LTLLKQFHSRYTEQF	WASHC5	1081	Q12768
DSRHPLTYRKTTNFA	ZFHX2	1166	Q9C0A1
KQLEALSYARHFQPF	RMND5B	211	Q96G75
FDSLSHKKYDPDLFR	RYR3	2546	Q15413
PYAHTRKSFSISDKL	TRPM3	1671	Q9HCF6
FITLFVEKLPNHRDY	STAMBPL1	81	Q96FJ0
SFVVSSLDPDHKYRF	TNXB	1211	P22105
SANKYEEIHLPRFSL	TEX43	26	Q6ZNM6
LTYEKRFSSPHQSLL	SCN2A	546	Q99250
HFPYLLTLQLKRFDF	USP47	381	Q96K76
RLPTINKHSFRYFVL	RALGAPB	936	Q86X10
SPDLTLYHFFNEVLR	TAS1R2	276	Q8TE23
LYPVSRFSNVKSLQH	SOCS7	506	O14512
ALNSLYSPKIEVHFL	PRKDC	2541	P78527
KFCRLITYSHSSPQL	nan	101	Q86TA4
KSFSRKPSLSYHQRF	ZNF587B	361	E7ETH6
TRKICHSLYFPQSLD	USP41	266	Q3LFD5
SPRHYSEFIEFLSKA	ZSWIM6	1161	Q9HCJ5
ESSFATQALRKPHLY	TTC7A	316	Q9ULT0
RYNESKKPFSFHSDL	ZNF483	331	Q8TF39
FYFLKIASSSHPLFL	TAS2R8	106	Q9NYW2
FFRRTIQKNLHPTYS	THRA	76	P10827
LKFTPYQSIATHSAR	TSPEAR	411	Q8WU66
TRKICHSLYFPQSLD	USP18	266	Q9UMW8
LSTFPTQRDSSLFYH	TBX4	321	P57082
EFLTLLFKYTFHQPT	XPO6	396	Q96QU8
IFPSHISSRYLRFFE	TTLL4	1026	Q14679
QHQRYFVKALTPAFL	TTC4	351	O95801
SFLESNYFTKPNLKH	ZFC3H1	1046	O60293
KLFFRRHYPVNSITF	TNS2	1331	Q63HR2
YQFFEDRHSAIKLRP	UGGT1	966	Q9NYU2
HLARRLKNNSFYPFV	TMEM249	31	Q2WGJ8
LVDKKHPEFSSSYNR	VPS13D	1791	Q5THJ4
EYLLRLFSSPNKLHF	KCNF1	236	Q9H3M0
TYVRLKFHTSRPESF	LAMC3	131	Q9Y6N6
SRPYLFLDSTHKELK	MYO1B	901	O43795
EKLHLSSPDNFRYLN	MYO6	261	Q9UM54
CLLHGSKSYFFRQPT	GRIN2B	1396	Q13224
YTFKDFLLRPRSHKS	NEDD4L	126	Q96PU5